Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II—results

Blute, Michael L.; Ackerman, Stacey J.; Rein, Alisoh L; Beusterien, Kathleen; Sullivan, Erin; Tanio, Craig P; Strauss, Michael J.; Manyak, Michael J.

doi:10.1016/s0090-4295(00)00829-3

Cited by 29 publications

(18 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One study by Ackerman and colleagues was published in three papers, [78][79][80] and another by DiSantostefano and colleagues was published in two papers. 74,81 The third study by Howard and Wortley was published as a technology assessment report for the Australian Medical Services Advisory Committee (MSAC).…”

Section: Studies Selected For Critiquementioning

confidence: 99%

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Lourenço

Armstrong²,

N’Dow³

et al. 2008

Health Technol Assess

117

View full text Add to dashboard Cite

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Lourenco, T.; Armstrong, N.; N'Dow, J.; Nabi, G.; Deverill, M.; Pickard, R.; Vale, L.; MacLennan, G.; Fraser, C.; McClinton, S.; Wong, S.; Coutts, A.; Mowatt, G.; Grant, A. Published in: Health Technology Assessment Publication date: 2008 Document VersionPublisher's PDF, also known as Version of record Link to publication in Discovery Research Portal Citation for published version (APA):Lourenco, T., Armstrong, N., N'Dow, J., Nabi, G., Deverill, M., Pickard, R., ... Grant, A. (2008). Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technology Assessment, 12(35). General rightsCopyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.• You may not further distribute the material or use it for any profit-making activity or commercial gain.• You may freely distribute the URL identifying the publication in the public portal. Take down policyIf you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 12. May. 2018 Health Technology Assessment 2008; Vol. 12: No. 35 Health Technology Assessment NIHR HTA Programme www.hta.ac.uk November 2008 Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below).Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £3...

show abstract

Section: Studies Selected For Critiquementioning

confidence: 99%

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Lourenço

Armstrong²,

N’Dow³

et al. 2008

Health Technol Assess

117

View full text Add to dashboard Cite

show abstract

“…Blute et al [41] performed a CUA comparing transurethral microwave thermotherapy (TUMT) with α-blocker medical therapy and with TURP in men with moderate to severe symptoms. Utilities for BPH-related health states were defined for risk-averse and non-risk-averse patients.…”

Section: Calculating Cost-effectivenessmentioning

confidence: 99%

The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states

Taub¹,

Wei

2006

Curr Urol Rep

View full text Add to dashboard Cite

Throughout the past several decades, interest in health care economics has increased as health care spending has soared--currently in excess of 1.5 trillion dollars and comprising approximately 16% of the nation's Gross Domestic Product. Benign prostatic hyperplasia (BPH) and its associated clinical manifestation of lower urinary tract symptoms is one of the most common medical conditions of aging men. BPH has been, and continues to be, a major factor in health care expenditures in the United States, costing up to 4 billion dollars each year. During the past 15 years, considerable changes in the patterns of care for BPH patients have evolved, resulting in similarly profound economic alterations. In this article, we examine contemporary trends in practice patterns for BPH and their associated impact on the cost of care for this condition.

show abstract

“…19,20 In the short term, minimally invasive surgical therapies such as TUMT have been shown to be less expensive and as effective or less effective than TURP. [21][22][23][24] In contrast, patients choosing a treatment pathway starting with medical therapy and ending with successful TURP or open simple prostatectomy, have the highest lifetime treatment costs. 19,25,26 The evidence supporting these results is not of high-level since only five studies address the longterm cost consequences or cost effectiveness of various BPH treatment alternatives beyond a few years period.…”

Section: Cost Differences Between Various Bph Treatment Optionsmentioning

confidence: 99%

“…In addition, cost-effectiveness data have favoured the use of TUMT over TURP. 21,29,[32][33][34] In a prospective study in which patients were followed up for over a 2-year period, TUMT showed lower primary costs, lower complications but higher re-treatment costs compared with TURP. 24 On the other hand, using a Markov model, DiSantostefano et al examined the clinical and cost consequences over a 20-year period of watchful waiting (WW), pharmacotherapy, TUMT and TURP.…”

Section: Cost Differences Between Various Bph Treatment Optionsmentioning

confidence: 99%

Photoselective vaporization of the prostate. Review of cost implementation to BPH treatment

Alivizatos

Skolarikos

2007

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

Effective treatment of benign prostatic hyperplasia (BPH) involves not only a reduction of symptom scores and the prevention of serious complications, but also an improvement in overall patient's quality of life and cost effectiveness. There is a paucity of data regarding cost effectiveness when the pharmacologic, the minimally invasive and the surgical treatments of BPH are compared. The potassium-titanyl-phosphate laser prostatectomy seems to be a safe and effective treatment option both in the short and in the long-term run. Preliminary results indicate that photoselective vaporization of the prostate is also a cost-effective method when compared to different minimally invasive treatments and to the transurethral prostatectomy.

show abstract

Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II—results

Abstract: From a societal perspective, thermotherapy appears to be a reasonable and cost-effective alternative to both medical and surgical treatment. However, the actual treatment decision should be based on multiple factors, only one of which is cost effectiveness.

Cited by 29 publications

References 21 publications

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states

Photoselective vaporization of the prostate. Review of cost implementation to BPH treatment

Contact Info

Product

Resources

About